← Back
Data updated: Jul 17, 2026
THE VERARD COMPANY
Pharma Pharmaceuticals
THE VERARD COMPANY is a pharmaceutical company with 1 FDA-approved products.
1939
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
Upcoming FDA Decisions
Full Calendar → Jul 23, 2026 — Rivoceranib + camrelizumab
5d Jul 23, 2026 — Rivoceranib + camrelizumab
Aug 13, 2026 — LNTH
THE VERARD COMPANY's Key Drugs
THE VERARD COMPANY's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
THE VERARD COMPANY's Recent FDA Approvals
New NDA/BLA approvals for THE VERARD COMPANY over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
THE VERARD COMPANY's Therapeutic Areas
Disease areas where THE VERARD COMPANY has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
THE VERARD COMPANY Pipeline Snapshot
Active clinical trials for THE VERARD COMPANY across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1939-08-30
- Latest
- 1939-08-30
- Applications
- 1